Followers | 210 |
Posts | 11026 |
Boards Moderated | 1 |
Alias Born | 04/20/2011 |
Friday, November 21, 2014 12:21:24 PM
These developments mean that new markets for cannabis research, medical use, and recreational use will be opening up all the time. It only takes one company as industrious as Cannagrow to seize upon these new markets and elevate share value. Take for example GW Pharmaceuticals (NASDAQ:GWPH), which now trades at 71.34 after successfully developing a portfolio of cannibinoid treatments that includes Sativex, a cannabis-based drug that alleviates spasticity in Multiple Sclerosis and has been shown to help pain symptoms from cancer. Sativex is used in 15 different countries, and it appears to be only a matter of time before it makes its way to the U.S.
I am a trader, only a trader. my posts are my opinion and are
not for sale. I do my DD, I advise you to do yours. My posts
are not recommendations to buy or sell. I have never and
will not accept payment to post on any stock. So don't ask.
Endexx Corporation (EDXC) Leverages Global Market Trends and Legislative Reforms to Spearhead Growth in the Cannabis and Plant-Based Wellness Sectors • EDXC • Mar 27, 2024 3:01 PM
Applied UV, Inc. Announces Pricing of $2.76 Million Registered Direct and Private Placement Priced at the Market Under Nasdaq Rules • AUVI • Mar 27, 2024 2:51 PM
POET and MultiLane Collaborate to Develop High-Speed Pluggable Transceivers for AI Networks • POET • Mar 27, 2024 10:52 AM
Maybacks Global Entertainment Opens 23 More Stations in Important Major Cities • AHRO • Mar 27, 2024 9:00 AM
NxGen Brands Inc. Forecast to Deliver 140% Growth in Q1 2024 • NXGB • Mar 27, 2024 7:30 AM
Kona Gold Beverages, Inc. Strategic Advancements: Covert LLC Introduces Federally Legal D9 Gummies and Revamps Innovative eCommerce Platform, Propelling Toward $12 Million Annual Revenue Goal • KGKG • Mar 26, 2024 8:30 AM